Influence on sCD40L Value According to ELISA Assay Kits

Area of Science:

• Biomarker Discovery
• Immunology
• Clinical Chemistry

Background:

• Soluble CD40 Ligand (sCD40L) is a potential biomarker for thrombotic risk and cancer progression.
• Accurate sCD40L measurement is vital for research and clinical applications.
• Standardization challenges arise from preanalytic variations, sample types, and differing ELISA kit reference ranges, affecting biobanking and reproducibility.

Purpose of the Study:

• To compare sCD40L measurements between two ELISA kits.
• To establish reference ranges for sCD40L using Bayesian statistical methods.
• To assess the impact of sample type (serum vs. plasma) on sCD40L levels.

Main Methods:

• sCD40L levels were quantified using two distinct ELISA kits.
• Bayesian statistical analysis was employed to define reference ranges for each kit.
• Paired t-tests and Pearson's correlation coefficients were used to compare kit results.

Main Results:

• Significant differences in sCD40L reference ranges were observed between the R&D kit (1,095.48 - 6,603.00 pg/mL) and the Invitrogen kit (1,620.00 - 10,405.00 pg/mL).
• A statistically significant difference (p = 0.0019) was found between the kits.
• A strong positive correlation (r = 0.88) was noted for sCD40L levels in serum samples.

Conclusions:

• ELISA kit selection significantly impacts sCD40L reference values, necessitating institution-specific ranges.
• Serum is the preferred sample type over plasma for sCD40L analysis.
• Standardized reference ranges are essential to enhance the reliability of sCD40L as a biomarker in research.